Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04667702 · ClinicalTrials.gov registry record
HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases
A clinical trial of Human Papilloma Virus Vaccine Hesitancy, sponsored by Indiana University.
- Completed
- Registry status
- 176
- Enrollment target
- 1
- Study location
NCT04667702 is a study of Human Papilloma Virus Vaccine Hesitancy that has completed, run by Indiana University. The registered enrollment target is 176 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04667702, a study of Human Papilloma Virus Vaccine Hesitancy, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
For the identified groups of patients (survivors of childhood cancer and youth with sickle cell disease) the investigators want to better understand the barriers to, and facilitators of, HPV vaccination. Through HCP interviews the investigators will also assess both attitudinal and logistical obstacles to HPV vaccination. Some subspecialty HCPs may believe, for instance, that it is the primary care provider's responsibility to vaccinate or they may be unfamiliar with the requirement to enter vaccination data into CHIRP. Also, in some cases HPV vaccine may not be readily available in subspecialty clinic locations and/or subspecialty HCPs may not be Vaccines for Children (VFC) providers. Participants: the investigators will focus on two patient groups: survivors of childhood cancer, which includes children aged 9-21 years who have completed active therapy for cancer and are eligible for vaccination, and sickle cell disease, which includes children aged 9-21 years with a diagnosis of sickle cell disease. The investigators will recruit parents of children aged 9-21 years and older adolescents aged 18-21 years. For pediatric patients, the investigators selected a lower age of 9 years because HPV vaccine is licensed down to 9 years of age, and an upper limit of 21 years, as that is considered the upper bound of adolescence by the American Academy of Pediatrics. For patients 9-17 years of age, only parents will be interviewed by video or phone because parents are the vaccine decision-makers. For patients 18-21 years of age, the investigators will interview both young adults and their parents, because, while the young adult has legal decision-making capacity, in reality, the decision is frequently made jointly by the young adult and parent, and older adolescents are frequently unwilling to go against their parents' wishes. All research procedures will be conducted in English. Participants will be excluded if they have an intellectual disability or severe medical illness suc
Conditions Studied
Interventions
- BEHAVIORAL Interviews
Study Locations (1)
Indiana
- Riley Hospital for Children - Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2022-07-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04667702
The ClinicalTrials.gov registry entry for NCT04667702 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Papilloma Virus Vaccine Hesitancy appearing as the primary indexed condition, and to 1 intervention - of which Interviews is the first listed.
NCT04667702 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT04667702 about?
NCT04667702 is a clinical study titled "HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases". For the identified groups of patients (survivors of childhood cancer and youth with sickle cell disease) the investigators want to better understand the barriers to, and facilitators of, HPV vaccination. Through HCP interviews the investigators will also assess both attitudinal and logistical obstac...
What is the current status of trial NCT04667702?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2021-01-04. Estimated completion is 2022-07-05.
What conditions does trial NCT04667702 study?
This clinical trial studies the following conditions: Human Papilloma Virus Vaccine Hesitancy.
What interventions are being tested in trial NCT04667702?
The interventions under investigation include: Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT04667702?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04667702 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.